RPS Cancer Lab, under the leadership of Prof. Rana P. Singh at Jawaharlal Nehru University (JNU), New Delhi, stands at the forefront of cutting-edge research in cancer biology and therapeutics. Prof. Singh, a distinguished cancer biologist and currently the Vice Chancellor of Gautam Buddha University (GBU), has dedicated over three decades to unraveling the complexities of cancer progression and exploring innovative strategies for its prevention and treatment.

The lab is committed to investigating the intricate molecular mechanisms that drive cancer development, progression, and metastasis. Central to its research philosophy is a multidisciplinary approach that integrates molecular biology, cell signaling, oxidative stress biology, tumor angiogenesis, and experimental therapeutics. The team places a special emphasis on identifying and evaluating non-toxic, mechanism-based anticancer agents derived from natural sources, particularly phytochemicals, with the potential to serve as chemopreventive and therapeutic agents.

At RPS Cancer Lab, state-of-the-art facilities and advanced experimental models — including in vitro cell culture systems, in vivo animal models, and genetically tractable Drosophila melanogaster models — are employed to dissect the molecular pathways involved in carcinogenesis. The lab is actively involved in exploring how natural compounds can modulate key processes such as oxidative stress, apoptosis, angiogenesis, and immune responses, with the goal of developing effective combination therapies alongside conventional chemotherapy and radiotherapy.

The lab’s research ecosystem thrives on international collaborations and academic partnerships. Notably, Prof. Singh has played a pivotal role in establishing the "Centre for Integrative Cancer Biology and Therapeutics" in collaboration with prestigious institutions like Stanford University and Oregon Health & Science University.

With a strong commitment to translational research and innovation, RPS Cancer Lab continues to contribute valuable insights to the global scientific community, working towards safer, more effective, and personalized approaches to cancer prevention and treatment.